Patent Assignment
Reel/Frame 020243/0259
Assignment of Assignor's Interest
Recorded: 2007-12-14
Pages: 14
Assignors
LUDWIG INSTITUTE FOR CANCER RESEARCH
Executed: 2007-12-03
LICENTIA LTD.
Executed: 2007-12-07
Assignee
VEGENICS LIMITED
LEVEL 1, 10 WALLACE AVE., TOORAK, VICTORIA, 3142, AUSTRALIA
Covered Properties
(47)
FLT4, a Receptor Tyrosine Kinase
Patent:
5,776,755 →
Application:
08/340,011 →
FH4 Ligand and Methods of Use
Patent:
6,221,839 →
Application:
08/510,133 →
Receptor Ligand
Patent:
6,245,530 →
Application:
08/585,895 →
Antibodies Reactive with Vegf-C, a Ligand for the FLT4 Receptor Tyrosine Kinase ( Vegfr-3)
Patent:
6,403,088 →
Application:
08/601,132 →
Receptor Ligand Vegf-C
Patent:
6,645,933 →
Application:
08/671,573 →
Vascular Endothelial Growth Factor C (Vegf-C) Acys 106 Protein and Gene, and Uses Thereof
Patent:
6,130,071 →
Application:
08/795,430 →
Antibodies to FLT4, a Receptor Tyrosine Kinase and Uses Thereof
Patent:
6,107,046 →
Application:
08/901,710 →
Vascular Endothelial Growth Factor-D (Vegf-D) Polypeptides
Patent:
6,235,713 →
Application:
08/915,795 →
FLT4 (Vegfr-3) as a Target for Tumor Imaging and Anti-Tumor Therapy
Patent:
6,824,777 →
Application:
09/169,079 →
Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D
Polynucleotides Encoding Vascular Endothelial Growth Factor D (Vegf-D)
Patent:
6,689,580 →
Application:
09/296,275 →
Vascular Endothelial Growth Factor C (Vegf-C) Protein and Gene, Mutants Thereof, and Uses Thereof
Patent:
6,361,946 →
Application:
09/355,700 →
Novel Neuropilin/Growth Factor Complexes and Uses Thereof
Patent:
6,515,105 →
Application:
09/421,365 →
Vascular Endothelial Growth Factor C (Vegf-C) Protein and Gene Mutants Thereof, and Uses Thereof
Patent:
6,818,220 →
Application:
09/534,376 →
Stimulation of Lymphatic Growth with an FLT4 Ligand
Patent:
6,730,658 →
Application:
09/631,092 →
FLT4 (Vegfr-3) as a Target for Tumor Imaging and Anti-Tumor Therapy
Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor Dnas and Proteins
Vegfr-3 Inhibitor Materials and Methods
Vascular Endothelial Growth Factor D(Vegf-D) Antibodies and Methods of Use
Progenitor Cell Materials and Methods
Neuropilin/VEGF-C/VEGFR-3 materials and methods
Application:
10/262,538 →
Publication:
US 2003/0113324
Vascular Endothelial Growth Factor D (Vegf-D) Antibodies and Vectors, and Methods of Use
Soluble Neuropilin/Growth Factor Receptor Fusion Proteins
Modulation of VEGF-C/VEGFR-3 interactions in the treatment of rheumatoid arthritis
Application:
10/326,048 →
Publication:
US 2004/0120950
Lymphatic endothelial cells materials and methods
Application:
10/483,203 →
Publication:
US 2006/0269548
Lymphatic and blood endothelial cell genes
Application:
10/505,928 →
Publication:
US 2006/0088532
Lymphatic and blood endothelial cell genes
Application:
10/570,963 →
Publication:
US 2007/0110744
Therapy Targeting FLT4 (Veger-3) Expressed in Blood Vessels
Antibodies to Vegf-C
Vascular Endothelial Growth Factor C (Vegf-C) Protein and Gene, Mutants Thereof, and Uses Thereof
Use of VEGF-C or VEGF-D in reconstructive surgery
Application:
10/868,549 →
Publication:
US 2005/0043235
Heparin binding VEGFR-3 ligands
Application:
10/868,577 →
Publication:
US 2005/0032697
Use of VEGF-D gene to prevent restenosis
Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor Dnas and Proteins
Chimeric anti-VEGF-D antibodies and humanized anti-VEGF-D antibodies and methods of using same
Application:
11/074,373 →
Publication:
US 2006/0024302
Vegfr-3 Fusion Proteins
Multivalent antibody materials and methods for VEGF/PDGF family of growth factors
Application:
11/075,400 →
Publication:
US 2005/0282233
Compositions and methods for treatment of lymphatic and venous vessel arterialization
Application:
11/076,427 →
Publication:
US 2006/0025338
Antisense Nucleic Acid Sequence to Vascular Endothelial Growth Factor D (Vegf - D)
Application:
11/304,585 →
Publication:
US 2006/0177428
Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
Modified Vegf-a with Improved Angiogenic Properties
VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
Application:
11/600,479 →
Publication:
US 2007/0082848
Vascular endothelial growth factor D (VEGF-D) antibodies and vectors, and methods of use
Application:
11/692,753 →
Publication:
US 2008/0145366
Vascular Endothelial Growth Factor D (Vegf-D) Polypeptides and Methods of Use
Use of VEGF-C or VEGF-D in Reconstructive Surgery
Application:
11/782,225 →
Publication:
US 2008/0147045
Closed Loop Stepper Motor Control
Materials and Methods Involving Hybrid Vascular Endothelial Growth Factor Dnas and Proteins
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 12, 1996
From: ALITALO, KARI; JOUKOV, VLADIMIR
To: HELSINKI UNIVERSITY LICENSING, LTD.
Reel/Frame 008129/0688 →
Assignment of Assignor's Interest
Sep 20, 1996
From: ALITALO, KARI; JOUKOV, VLADIMIR
To: HELSINKI UNIVERSITY LICENSING, LTD.
Reel/Frame 008145/0829 →
Assignment of Assignor's Interest
Oct 1, 1996
From: ALITALO, KARI; JOUKOV, VLADIMIR
To: HELSINKI UNIVERSITY LICENSING, LTD.
Reel/Frame 008161/0909 →
Assignment of Assignor's Interest
Aug 13, 2001
From: ALITALO, KARI; JELTSCH, MARKKU M.
To: LICENTIA, LTD.
Reel/Frame 012078/0876 →
Assignment of Assignor's Interest
Sep 14, 2001
From: ALITALO, KARI; APRELIKOVA, OLGA; PAJUSOLA, KATRI; ARMSTRONG, ELINA
To: LICENTIA, LTD.
Reel/Frame 012165/0613 →
Assignment of Assignor's Interest
Jan 10, 2002
From: HELSINKI UNIVERSITY LICENSING, LTD.
To: LUDWIG INSTITUTE FOR CANCER RESEARCH, A SWISS NON-FOR-PROFIT CORPORATION
Reel/Frame 012481/0712 →
Merger and Change of Name
Jan 10, 2002
From: HELSINKI UNIVERSITY LICENSING, LTD. OY
To: LICENTIA LTD
Reel/Frame 012481/0904 →
Assignment of Assignor's Interest
Jan 10, 2002
From: ALITALO, KARI; JOUKOV, VLADIMIR
To: HELSINKI UNIVERSITY LICENSING, LTD. OY
Reel/Frame 012481/0709 →
Assignment of Assignor's Interest
Aug 8, 2003
From: LICENTIA LTD.
To: LUDWIG INSTITUTE FOR CANCER RESEARCH
Reel/Frame 014369/0173 →
Assignment of Assignor's Interest
Jan 13, 2004
From: LICENTIA LTD.
To: LUDWIG INSTITUTE FOR CANCER RESEARCH - A SWISS NOT-FOR-PROFIT CORPORATION
Reel/Frame 014875/0706 →
50% Assignment
Feb 6, 2004
From: LICENTIA, LTD.
To: LUDWIG INSTITUTE FOR CANCER RESEARCH, A SWISS NOT-FOR-PROFIT CORPORATION
Reel/Frame 014955/0503 →
Assignment of Assignor's Interest
Apr 19, 2004
From: MAKINEN, TAIJA
To: LICENTIA LTD.
Reel/Frame 015224/0728 →
Assignment of Assignor's Interest
Jun 7, 2004
From: ALITALO, KARI; KOIVUNEN, ERKKI; KUBO, HAJIME
To: LICENTIA LTD.
Reel/Frame 015426/0732 →
Change of Name
Apr 8, 2005
From: HELSINKI UNIVERSITY LICENSING LTD.
To: LICENTIA LTD.
Reel/Frame 016097/0582 →
Merger and Change of Name
Jan 10, 2007
From: HELSINKI UNIVERSITY LICENSING LTD.
To: LICENTIA LTD.
Reel/Frame 018757/0418 →
Merger and Change of Name
Jan 24, 2007
From: HELSINKI UNIVERSITY LICENSING LTD.
To: LICENTIA LTD.
Reel/Frame 018815/0306 →
Change of Name
Oct 14, 2011
From: VEGENICS LIMITED
To: VEGENICS PTY LTD
Reel/Frame 027066/0540 →
Change of Name
Jan 19, 2012
From: VEGENICS LIMITED
To: VEGENICS PTY LTD
Reel/Frame 027567/0286 →
Change of Name
Jan 3, 2013
From: VEGENICS LIMITED
To: VEGENICS PTY LTD
Reel/Frame 029565/0926 →